INVO FertilityIVF -2.59%35 WACC % is 20.03% as of Jul. 10, 2026, which is 1% below its 10-year median of 20.23. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $134.71 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 864 Medical Devices & Instruments companies, INVO Fertility ranks worse than 96.41% on this metric.
As of today (2026-07-10), INVO Fertility's weighted average cost of capital is 20.03%%. INVO Fertility's ROIC % is -24.39% (calculated using TTM income statement data).
INVO Fertility earns returns that do not match up to its cost of capital. It will destroy value as it grows.
For a comprehensive WACC calculation, please access the WACC Calculator.
INVO Fertility (NAS:IVF) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, INVO Fertility's weighted average cost of capital is 20.03%%. INVO Fertility's ROIC % is -24.39% (calculated using TTM income statement data).
INVO Fertility earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
Related Terms
INVO Fertility WACC % Historical Data
* Premium members only.
The historical data trend for INVO Fertility's WACC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, INVO Fertility's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INVO Fertility WACC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's WACC % distribution charts can be found below:
* The bar in red indicates where INVO Fertility's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, INVO Fertility's market capitalization (E) is $2.018 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, INVO Fertility's latest one-year quarterly average Book Value of Debt (D) is $5.5166 Mil.
a) weight of equity = E / (E + D) = 2.018 / (2.018 + 5.5166) = 0.2678
b) weight of debt = D / (E + D) = 5.5166 / (2.018 + 5.5166) = 0.7322
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.561%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. INVO Fertility's beta is 2.1584.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.561% + 2.1584 * 6% = 17.5114%
3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, INVO Fertility's interest expense (positive number) was $1.174 Mil. Its total Book Value of Debt (D) is $5.5166 Mil.
Cost of Debt = 1.174 / 5.5166 = 21.2812%.
4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = -0.15 / -9.533 = 1.57%.
INVO Fertility's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC
=
E / (E + D)
*
Cost of Equity
+
D / (E + D)
*
Cost of Debt
*
(1 - Tax Rate)
=
0.2678
*
17.5114%
+
0.7322
*
21.2812%
*
(1 - 1.57%)
=
20.03%
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INVO Fertility (IVF) has a WACC % of 20.03% as of Jul. 10, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on INVO Fertility and its competitors. This is near median its historical median of 20.23. Over the past decade, INVO Fertility's WACC % has ranged from 2.83 to 385.78. According to the industry distribution chart, INVO Fertility ranks #833 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 96.4%.
Is INVO Fertility's WACC % too high?
INVO Fertility's current WACC % of 20.03% is near median its 10-year median of 20.23. Over the past 10 years, this metric has ranged from a low of 2.83 to a high of 385.78. The Medical Devices & Instruments industry median WACC % is 9.11. INVO Fertility's value of 20.03% is 120% above this industry median. Based on the distribution chart, INVO Fertility ranks #833 out of 864 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's WACC % compare to RMSL and ADMT?
According to the Medical Devices & Instruments industry distribution chart, INVO Fertility ranks #833 out of 864 companies for WACC %. This places INVO Fertility in the lower half of its industry. The industry median WACC % is 9.11. INVO Fertility's value of 20.03% is 120% above this benchmark. Historically, INVO Fertility's own WACC % has ranged from 2.83 to 385.78 over the past decade. While the company's 10-year median is 20.23 vs. the industry median of 9.11, INVO Fertility has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Medical Devices & Instruments company?
The median WACC % among Medical Devices & Instruments companies is 9.11, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. INVO Fertility's current WACC % of 20.03% is 120% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on INVO Fertility and its competitors. For the Medical Devices & Instruments industry, the median WACC % is 9.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. INVO Fertility's current WACC % is 20.03%, which is near median its own 10-year median of 20.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $134.71, compared to a current price of $1.13 — trading 99.2% below its estimated fair value. The current WACC % is 20.03%, which is near median its 10-year median of 20.23 and 120% above the Medical Devices & Instruments industry median of 9.11. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For INVO Fertility (IVF), the current WACC % is 20.03% as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is INVO Fertility (IVF) Overvalued in 2026?
Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued.
The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71.
GuruFocus considers INVO Fertility to be Possible Value Trap.
Key valuation signals for IVF:
WACC %: 20.03% (near median its 10-year median of 20.23)
GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
Industry Position: 120% above the Medical Devices & Instruments median (#833 of 864)
No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score
Get the complete analysis for IVF
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVF has been successfully added to your 
